Glycemic Targets: Standards of Medical Care in Diabetes-2018

被引:543
作者
不详
机构
关键词
AMERICAN-DIABETES-ASSOCIATION; INTENSIVE GLUCOSE CONTROL; LOOP INSULIN DELIVERY; BLOOD-GLUCOSE; HEMOGLOBIN A(1C); MICROVASCULAR COMPLICATIONS; SEVERE HYPOGLYCEMIA; OLDER-ADULTS; FOLLOW-UP; CARDIOVASCULAR OUTCOMES;
D O I
10.2337/dc18-S006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S55 / S64
页数:10
相关论文
共 86 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]   Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study [J].
Albers, James W. ;
Herman, William H. ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Martin, Catherine L. ;
Cleary, Patricia A. ;
Waberski, Barbara H. ;
Lachin, John M. .
DIABETES CARE, 2010, 33 (05) :1090-1096
[3]   REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes [J].
Aleppo, Grazia ;
Ruedy, Katrina J. ;
Riddlesworth, Tonya D. ;
Kruger, Davida F. ;
Peters, Anne L. ;
Hirsch, Irl ;
Bergenstal, Richard M. ;
Toschi, Elena ;
Ahmann, Andrew J. ;
Shah, Viral N. ;
Rickels, Michael R. ;
Bode, Bruce W. ;
Philis-Tsimikas, Athena ;
Pop-Busui, Rodica ;
Rodriguez, Henry ;
Eyth, Emily ;
Bhargava, Anuj ;
Kollman, Craig ;
Beck, Roy W. .
DIABETES CARE, 2017, 40 (04) :538-545
[4]   Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes [J].
Amiel, Stephanie A. ;
Aschner, Pablo ;
Childs, Belinda ;
Cryer, Philip E. ;
de Galan, Bastiaan E. ;
Heller, Simon R. ;
Gonder-Frederick, Linda ;
Frier, Brian M. ;
Jones, Timothy ;
Khunti, Kamlesh ;
Leiter, Lawrence A. ;
McCrimmon, Rory J. ;
Luo, Yingying ;
Seaquist, Elizabeth R. ;
Vigersky, Robert ;
Zoungas, Sophia .
DIABETES CARE, 2017, 40 (01) :155-157
[5]  
[Anonymous], NEW ENGL J MED
[6]  
[Anonymous], FDA EXP IND CONT GLU
[7]  
[Anonymous], FDA APPR 1 CONT GLUC
[8]  
[Anonymous], DIABETES
[9]   Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes [J].
Battelino, Tadej ;
Phillip, Moshe ;
Bratina, Natasa ;
Nimri, Revital ;
Oskarsson, Per ;
Bolinder, Jan .
DIABETES CARE, 2011, 34 (04) :795-800
[10]   The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading [J].
Beck, Roy W. ;
Connor, Crystal G. ;
Mullen, Deborah M. ;
Wesley, David M. ;
Bergenstal, Richard M. .
DIABETES CARE, 2017, 40 (08) :994-999